Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1
4(100.0%)
4Total
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05279742Phase 1Enrolling By Invitation

Enhancing the Natriuretic Peptide System in HFpEF

Role: lead

NCT00348556Phase 1Terminated

Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure

Role: lead

NCT00252187Phase 1Completed

Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure

Role: lead

NCT00387621Phase 1Completed

Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction

Role: lead

All 4 trials loaded